Point72 Asset Management
COYA icon

Point72 Asset Management’s Coya Therapeutics COYA Stock Holding History

Point72 Asset Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Sell
37,681
-23,903
-39% -$112K ﹤0.01% 3569
2025
Q4 		$357K Buy
+61,584
New +$374K ﹤0.01% 3398

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Point72 Asset Management's COYA Position: Q1 2026 in Review

Point72 Asset Management reduced its Coya Therapeutics (COYA) stake by 39% in Q1 2026, selling an estimated $112K and leaving 37,681 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Point72 Asset Management first reported a position in COYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $357K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Point72 Asset Management held 37,681 shares of Coya Therapeutics worth $148K as of Q1 2026.
  • Point72 Asset Management sold 23,903 Coya Therapeutics shares in Q1 2026, an estimated $112K.
  • Coya Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3569 holding.
  • Point72 Asset Management first reported a position in Coya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Point72 Asset Management's Coya Therapeutics position peaked at $357K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.